Clinical Trial

ShotBlocker, Cold Needling, and Both Methods in Combination Pain and Satisfaction

Completed
View on ClinicalTrials.gov →
Summary
Intramuscular (IM) injections are one of the most frequently used pharmacological treatment methods in nursing practice. Reducing the pain experienced by patients during this procedure and ensuring patient satisfaction are important indicators of treatment quality. Reducing injection-related pain should be a priority in nursing care for both patient safety and the effectiveness of the treatment process. This study is a trpile-blind, randomized, controlled trial. It was designed to evaluate the effects of ShotBlocker, cold needle, and a combination of both methods during intramuscular injection on patient pain levels and satisfaction. The research will be conducted in the injection unit affiliated with the Adult Emergency Department of Konya City Hospital, Ministry of Health of the Republic of Turkey. The study population will consist of patients who presented for cyanocobalamin injections, and the sample will consist of 132 individuals who voluntarily agreed to participate in the study and met the inclusion criteria. Before conducting the study, ethical approval will be obtained from the Necmettin Erbakan University Health Sciences Ethics Committee and from the Konya City Hospital of the Ministry of Health of the Republic of Turkey. Collected data will be analyzed using the SPSS statistical package program (version 22.0; SPSS Inc., USA). The Kolmogorov-Smirnov test will be used to assess whether the data exhibit a normal distribution; statistical significance will be accepted as p\<0.05.
Protocol Amendment History 2 changes
critical Trial completed 2026-05-19
minor Completion moved earlier: 2026-06-10 -> 2026-05-04 2026-05-19
Trial Details
NCT Number NCT07258953
Lead Sponsor Necmettin Erbakan University
Conditions Pain
Enrollment 132 participants
Start Date 2026-01-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-05-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-18